Breast cancer and NSAID use: a meta-analysis
2001

Breast Cancer and NSAID Use: A Meta-Analysis

publication Evidence: moderate

Author Information

Author(s): Khuder S A, Mutgi A B

Primary Institution: Medical College of Ohio

Hypothesis

Do non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of breast cancer?

Conclusion

NSAID use may be associated with a small decrease in the risk of breast cancer.

Supporting Evidence

  • The combined estimate of relative risk was 0.82.
  • The combined estimate for cohort studies was 0.78.
  • The combined estimate for case-control studies was 0.87.

Takeaway

Taking certain pain relievers called NSAIDs might help lower the chances of getting breast cancer.

Methodology

This meta-analysis examined 6 cohort studies and 8 case-control studies on NSAID use and breast cancer.

Limitations

The available data are insufficient to estimate the dose–response effect for duration and frequency of NSAID use.

Participant Demographics

Studies included females with varying case numbers.

Statistical Information

Confidence Interval

95% CI = 0.75–0.89

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1709

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication